ClinicalTrials.gov
public full text
Public Domain
Phase 1 Study of HBI0101 CAR-T in Refractory B-Cell Autoimmune Diseases
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- CAR-T Therapy Targeting CD19 and BCMA in Highly Sensitized Kidney Transplant Participants#245584
- Absence of autoantibodies linked to cancer and autoimmune disorders 26 weeks after BNT162b2 boosting in CoronaVac- primed individuals#253540
- Genetic and immunologic determinants of BCG disease: from mechanism to prevention#4597
- Safety and Efficacy of BAFF-R CART for Refractory Neuroimmune Diseases#1029969
- Combined Molecular B Cell and T Cell Compatibility Analysis for Enhanced Immunological Risk Stratification in Kidney Transplantation / Matthias Niemann#1038091
Record · ID 217044
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive